{"id":"https://openalex.org/W2016151216","doi":"https://doi.org/10.2174/157340611797928316","title":"Synergism from Combination of Cisplatin and Multicentred Platinums Coded as DH6Cl and TH1 in the Human Ovarian Tumour Models","display_name":"Synergism from Combination of Cisplatin and Multicentred Platinums Coded as DH6Cl and TH1 in the Human Ovarian Tumour Models","publication_year":2011,"publication_date":"2011-11-01","ids":{"openalex":"https://openalex.org/W2016151216","doi":"https://doi.org/10.2174/157340611797928316","mag":"2016151216","pmid":"https://pubmed.ncbi.nlm.nih.gov/22313299"},"language":"en","primary_location":{"id":"doi:10.2174/157340611797928316","doi":"https://doi.org/10.2174/157340611797928316","is_oa":false,"landing_page_url":"https://doi.org/10.2174/157340611797928316","pdf_url":null,"source":{"id":"https://openalex.org/S155723790","display_name":"Medicinal Chemistry","issn_l":"1573-4064","issn":["1573-4064","1875-6638"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010540175","display_name":"Ali S. Alshehri","orcid":"https://orcid.org/0000-0001-8257-9244","observed_orcids":["https://orcid.org/0000-0001-8257-9244"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Ali Alshehri","raw_affiliation_strings":["Discipline of Biomedical Science, School of Medical Sciences, Sydney Medical School, The University of Sydney, Cumberland Campus C42, 75 East Street, Lidcombe, NSW1825, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discipline of Biomedical Science, School of Medical Sciences, Sydney Medical School, The University of Sydney, Cumberland Campus C42, 75 East Street, Lidcombe, NSW1825, Australia","institution_ids":["https://openalex.org/I129604602"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056466058","display_name":"Philip James Beale","orcid":"https://orcid.org/0000-0003-3628-4597","observed_orcids":["https://orcid.org/0000-0003-3628-4597"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philip Beale","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000507391","display_name":"Jun Yu","orcid":"https://orcid.org/0000-0002-3390-5901","observed_orcids":["https://orcid.org/0000-0002-3390-5901"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jun Qing Yu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5023025221","display_name":"Fazlul Huq","orcid":"https://orcid.org/0000-0002-6932-4922","observed_orcids":["https://orcid.org/0000-0002-6932-4922"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Fazlul Huq","raw_affiliation_strings":["Discipline of Biomedical Science, School of Medical Sciences, Sydney Medical School, The University of Sydney, Cumberland Campus C42, 75 East Street, Lidcombe, NSW1825, Australia.,Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discipline of Biomedical Science, School of Medical Sciences, Sydney Medical School, The University of Sydney, Cumberland Campus C42, 75 East Street, Lidcombe, NSW1825, Australia.,Australia","institution_ids":["https://openalex.org/I129604602"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5023025221"],"corresponding_institution_ids":["https://openalex.org/I129604602"],"apc_list":null,"apc_paid":null,"fwci":0.1621,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.54839538,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"7","issue":"6","first_page":"593","last_page":"598"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10163","display_name":"Metal complexes synthesis and properties","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10163","display_name":"Metal complexes synthesis and properties","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13105","display_name":"Synthesis and pharmacology of benzodiazepine derivatives","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9890000224113464},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.6079999804496765},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.8050000071525574},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.8659999966621399},{"id":"https://openalex.org/keywords/a2780-cells","display_name":"A2780 cells","score":0.8939999938011169},{"id":"https://openalex.org/keywords/cisplatin-resistance","display_name":"cisplatin resistance","score":0.9649999737739563},{"id":"https://openalex.org/keywords/dna-adducts","display_name":"DNA adducts","score":0.7540000081062317},{"id":"https://openalex.org/keywords/nucleobase-adducts","display_name":"nucleobase adducts","score":0.703000009059906},{"id":"https://openalex.org/keywords/palladium-complexes","display_name":"palladium complexes","score":0.8399999737739563},{"id":"https://openalex.org/keywords/reversal-of-drug-resistance","display_name":"drug resistance reversal","score":0.3799999952316284}],"concepts":[{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.8314629793167114},{"id":"https://openalex.org/C2780443040","wikidata":"https://www.wikidata.org/wiki/Q3737863","display_name":"Bifunctional","level":3,"score":0.7180164456367493},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5627672076225281},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.5580021739006042},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5490536689758301},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.5012698173522949},{"id":"https://openalex.org/C61234307","wikidata":"https://www.wikidata.org/wiki/Q422960","display_name":"Nucleobase","level":3,"score":0.48076149821281433},{"id":"https://openalex.org/C108204754","wikidata":"https://www.wikidata.org/wiki/Q353392","display_name":"Adduct","level":2,"score":0.4543856382369995},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.4533133804798126},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.41006630659103394},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4052310585975647},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.3969504237174988},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36351868510246277},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3397709131240845},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.33897703886032104},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2649533748626709},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.25573718547821045},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1237657368183136},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009944","descriptor_name":"Organoplatinum Compounds","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D009944","descriptor_name":"Organoplatinum Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009944","descriptor_name":"Organoplatinum Compounds","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016923","descriptor_name":"Cell Death","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/157340611797928316","doi":"https://doi.org/10.2174/157340611797928316","is_oa":false,"landing_page_url":"https://doi.org/10.2174/157340611797928316","pdf_url":null,"source":{"id":"https://openalex.org/S155723790","display_name":"Medicinal Chemistry","issn_l":"1573-4064","issn":["1573-4064","1875-6638"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:22313299","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22313299","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicinal chemistry (Shariqah (United Arab Emirates))","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2290747338","https://openalex.org/W2087347607","https://openalex.org/W2305642248","https://openalex.org/W7015445350","https://openalex.org/W2563985028","https://openalex.org/W3094022023","https://openalex.org/W2096211459","https://openalex.org/W1803197392","https://openalex.org/W2191878334","https://openalex.org/W1757069527"],"abstract_inverted_index":{"Development":[0],"of":[1,7,19,24,50,94,178,208,230,247,267,295],"drug":[2,35,220],"resistance":[3,36],"and":[4,37,61,69,80,97,119,122,145,150,199,226,232,259,278],"the":[5,11,39,48,64,87,92,98,110,134,159,165,176,188,196,206,219,275,289,293,301,319],"presence":[6,294],"dose-limiting":[8],"side-effects":[9],"remain":[10],"two":[12,54,160,296,314],"main":[13],"problems":[14],"in":[15,33,45,63,86,91,109,141,187,195,217,234,274,284,305,309],"cancer":[16,71],"chemotherapy.":[17],"Combination":[18],"drugs":[20],"with":[21,53,84,107,133,143,169,180,210,249,272,288],"different":[22],"mechanisms":[23],"action":[25],"can":[26],"offer":[27,214,252],"a":[28,170,253,265],"distinct":[29],"advantage":[30,216],"over":[31],"monotherapy":[32],"overcoming":[34,218],"reducing":[38],"side-effects.":[40],"In":[41,222],"this":[42],"study":[43],"synergism":[44,155,183],"activity":[46],"from":[47],"combinations":[49,207,229,246],"cisplatin":[51],"(Cis)":[52],"multicentred":[55],"platinum":[56],"complexes":[57],"coded":[58],"as":[59],"TH1":[60,79,121,144,211,258,277,306],"DH6Cl":[62,81,123,146,233,250,260,310],"human":[65],"ovarian":[66],"A2780,":[67],"A2780cisR":[68],"A27800473R":[70],"cell":[72,191,201,236],"lines":[73],"had":[74],"been":[75],"investigated.":[76],"Although":[77,256],"Cis,":[78],"all":[82],"bind":[83],"nucleobases":[85,108,273],"DNA,":[88,276],"they":[89,101],"differ":[90,283],"nature":[93],"adducts":[95,116,132,271],"formed":[96],"non-covalent":[99,286],"interactions":[100,287],"may":[102,251],"undergo.":[103],"Whereas":[104],"Cis":[105,140,179,209,231,248],"binds":[106],"DNA":[111,290],"forming":[112],"mainly":[113,128],"intrastrand":[114],"bifunctional":[115,130],"such":[117],"1,2-Pt(GG)":[118],"1,2-Pt(AG),":[120],"are":[124,261,280],"expected":[125,262,281],"to":[126,240,263,282,292,300,318],"form":[127,264],"interstrand":[129,269],"G-Pt.....Pt-G":[131],"DNA.":[135],"It":[136],"was":[137,156,184],"found":[138,239],"that":[139,205,245],"combination":[142,177],"produced":[147,157,185],"both":[148,257],"sequence-":[149],"concentration-dependent":[151],"synergism.":[152],"Generally":[153],"greater":[154],"when":[158],"compounds":[161],"were":[162,238],"added":[163],"at":[164],"same":[166],"time":[167,173],"than":[168],"4":[171],"h":[172,225,228],"gap.":[174],"For":[175],"TH1,":[181],"significant":[182],"only":[186],"parent":[189],"A2780":[190],"line":[192,237],"but":[193,307],"not":[194,213,308],"resistant":[197],"A2780(cisR)":[198,235],"A2780(0473R)":[200],"lines,":[202],"thus":[203,243],"indicating":[204,244],"would":[212],"any":[215],"resistance.":[221],"contrast,":[223],"0/0":[224],"4/0":[227],"be":[241],"synergistic,":[242],"therapeutic":[254],"advantage.":[255],"number":[266],"long-range":[268],"G-Pt......Pt-G":[270],"DHCl":[279],"their":[285],"due":[291],"3-hydroxypyridine":[297],"ligands":[298,316],"bound":[299,317],"central":[302,320],"metal":[303],"ion":[304],"which":[311],"instead":[312],"contains":[313],"ammino":[315],"palladium":[321],"ion.":[322]},"counts_by_year":[{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}